Rescuing the last-line polymyxins: achievements and challenges

SC Nang, MAK Azad, T Velkov, QT Zhou, J Li - Pharmacological reviews, 2021 - ASPET
Antibiotic resistance is a major global health challenge and, worryingly, several key Gram
negative pathogens can become resistant to most currently available antibiotics. Polymyxins …

[HTML][HTML] The “old” and the “new” antibiotics for MDR gram-negative pathogens: for whom, when, and how

I Karaiskos, S Lagou, K Pontikis, V Rapti… - Frontiers in public …, 2019 - frontiersin.org
The recent expansion of multidrug resistant and pan-drug-resistant pathogens poses
significant challenges in the treatment of healthcare associated infections. An important …

Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing

CJY Tsai, JMS Loh, T Proft - Virulence, 2016 - Taylor & Francis
abstract Galleria mellonella (greater wax moth or honeycomb moth) has been introduced as
an alternative model to study microbial infections. G. mellonella larvae can be easily and …

Galleria mellonella as an infection model: an in-depth look at why it works and practical considerations for successful application

MF Pereira, CC Rossi, GC da Silva… - Pathogens and …, 2020 - academic.oup.com
The larva of the greater wax moth Galleria mellonella is an increasingly popular model for
assessing the virulence of bacterial pathogens and the effectiveness of antimicrobial agents …

Colistin and tigecycline resistance in carbapenemase‐producing Gram‐negative bacteria: emerging resistance mechanisms and detection methods

J Osei Sekyere, U Govinden, LA Bester… - Journal of applied …, 2016 - academic.oup.com
A literature review was undertaken to ascertain the molecular basis for tigecycline and
colistin resistance mechanisms and the experimental basis for the detection and delineation …

Colistin: still a lifesaver for the 21st century?

I Karaiskos, M Souli, I Galani… - Expert opinion on drug …, 2017 - Taylor & Francis
Introduction: Living in the 'era of antibiotic resistance'and facing the threat of an 'end to
antibiotics', physicians in the last decade have revived use of colistin, since the available …

[HTML][HTML] Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates

C Stein, O Makarewicz, JA Bohnert, Y Pfeifer… - PloS one, 2015 - journals.plos.org
The spread of carbapenem-non-susceptible Klebsiella pneumoniae strains bearing different
resistance determinants is a rising problem worldwide. Especially infections with KPC …

Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens

C Chen, J Shi, D Wang, P Kong, Z Wang… - Critical Reviews in …, 2024 - Taylor & Francis
The widespread antimicrobial resistance (AMR) calls for the development of new
antimicrobial strategies. Antibiotic adjuvant rescues antibiotic activity and increases the life …

Combination therapy for extensively-drug resistant gram-negative bacteria

I Karaiskos, A Antoniadou… - Expert review of anti …, 2017 - Taylor & Francis
Introduction: The ongoing crisis and emergence of extensively-drug resistant (XDR) gram-
negative pathogens in the nosocomial setting is worrisome. The limited armamentarium in …

In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii

W Ni, Y Wang, X Ma, Y He, J Zhao, J Guan, Y Li… - European Journal of …, 2022 - Springer
We investigated activities of cefiderocol combination therapy against carbapenem-resistant
Acinetobacter baumannii (CR-AB). A total of 123 clinical isolates of CR-AB, including 44 …